Daedalus Innovations is a biotechnology company focused on providing the tools and methodology to perform structural studies on what are typically considered intractable macromolecules.
 
Daedalus was formed in 2005 to make available the powerful reverse micelle technology to the research community.  Research on this technique was originally performed at SUNY-Buffalo in the late 90's.  More recent work was carried out at the University of Pennsylvania.  Daedalus is the sole licensor of the core patents for this technology.


The Founding Members:

Ronald W. Peterson
President & CSO

ron@daedalusinnovations.com

A. Joshua Wand
Member / Consultant

josh@daedalusinnovations.com

Brian G. Lefebvre
Member / Consultant

brian@daedalusinnovations.com